Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: August 2013
-
The American Bar Association (ABA) Section of Science and Technology, Section of Intellectual Property Law, and Center for Professional Development will be offering a live webinar entitled "Biosimilars and the BPCI Act: Where Are We Now and Where Are We Going?" on September 19, 2013 from 2:00 to 3:30 pm (Eastern). Ken Burchfiel of Sughrue…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Filing a Post-grant Proceeding with Concurrent Litigation: Strategic Considerations" on September 4, 2013 beginning at 2:00 pm (ET). A panel consisting of Erika Arner of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Dion Bregman of Morgan, Lewis & Bockius LLP; Juliana Mirabilio, Senior…
-
Foley & Lardner will be offering a web conference entitled "Lessons from the Inaugral Year of New Post-Grant Patent Office Proceedings: What Separates the Winners from the Losers?" on September 10, 2013 from 1:00 to 2:00 pm (Eastern). Featured panelists for the web conference will include C. Edward Polk, Jr., Chief Litigation Officer at Exela…
-
By Andrew Williams — As we have previously reported, the patent system is under attack, and has been for quite some time. Generally, these attacks either begin with the assumption that the patent system is "broken," or that conclusion is reached after a review of anecdotal accounts of alleged patent abuses. Rarely are these attacks…
-
By Kevin E. Noonan — The Supreme Court, in Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570 (2007), and Ashcroft v. Iqbal, 556 U.S. 662 (2009), has in recent years focused the requirements for pleadings under the Federal Rules of Civil Procedure and, concoimitantly, increased the scope of the bases a party can argue…
-
By Donald Zuhn — Last week, the American Civil Liberties Union (ACLU), ACLU of Utah Foundation, Inc., Public Patent Foundation (PUBPAT), Association for Molecular Pathology (AMP), Breast Cancer Action, and AARP submitted an amici curiae brief in two infringement actions brought by Myriad Genetics, Inc. (and the University of Utah Research Foundation, Trustees of the…
-
By Donald Zuhn — In a white paper released earlier this month, Professor Brook Baker of the Northeastern University School of Law argues that current trade agreements do not provide data exclusivity for biologics, and therefore, that the twelve countries negotiating the Trans-Pacific Partnership Agreement (TPP) "can and should apply their minds to potential costs of…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Purdue Pharmaceutical Products L.P. et al. v. TWi Pharmaceuticals, Inc.1:13-cv-05999; filed August 22, 2013 in the Northern District of Illinios • Plainiffs: Purdue Pharmaceutical Products L.P.; Purdue Pharma L.P.; Transcept Pharmaceuticals, Inc.• Defendant: TWi Pharmaceuticals,…
-
August 28, 2013 – Versata v. SAP and Fresenius v. Baxter: Res Judicata and Collateral Estoppel in Post-grant Proceedings and Concurrent Litigation (Intellectual Property Owners Association) – 2:00 to 3:00 pm (ET) August 29, 2013 – AIA Impact on Section 102 and Prior Art: Navigating the Expanded Scope of Prior Art and the AIA Exceptions…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Versata v. SAP and Fresenius v. Baxter: Res Judicata and Collateral Estoppel in Post-grant Proceedings and Concurrent Litigation" on August 28, 2013 beginning at 2:00 pm (ET). A panel consisting of Bernard Knight, General Counsel of the U.S. Patent and Trademark Office; Jeffrey…
Patent Docs 